Table 1.
Patient characteristics of the AIO-YMO-PAK-0515 cohort
| Median overall survival,a months (95% CI) | ||
|---|---|---|
| All patients, n (%) | 115 (100) | 20.0 (16.3-23.7) |
| Median age (range),b years | 69 (41-84) | |
| Gender, n (%) | ||
| Male | 54 (47) | |
| Female | 61 (53) | |
| Diagnosis of pulmonary metastases, n (%) | ||
| Radiographic | 84 (73) | |
| Histological | 31 (27) | |
| Stage at initial diagnosis, n (%) | ||
| Resectable PDAC | 66 (57) | 28.0 (17.7-38.3) |
| Locally advanced PDAC | 12 (10) | 20.0 (17.2-22.7) |
| Metastatic PDAC | 37 (32) | 19.0 (13.6-24.4) |
CI, confidence interval; PDAC, pancreatic ductal adenocarcinoma.
a
Median overall survival was calculated from the time of initial diagnosis of pulmonary metastases (i.e. time of pulmonary relapse for patients with resectable PDAC at initial diagnosis/time of progression with pulmonary metastases for patients with locally advanced PDAC).
b
Age was not available for patients from Charité Berlin.